![]() Improved compliance is the main point of interest for combination drugs in Europe and other countries. Konstas, MD, PhD, associate professor and head of the glaucoma service at the A University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece. Sometimes they also reduce the cost of daily therapy,” said Anastasios G.P. They enhance compliance and reduce the inconvenience. “I think the main advantage with fixed combinations, and this has been shown not only in ophthalmology but in general medicine, is that they reduce the number of bottles used. Two combinations are already in wide use, and ophthalmologists are anticipating the release of three more. The convenience, efficacy and affordability of combination glaucoma therapies are fueling their increased use in Europe as well as the Asia-Pacific region. If you continue to have this issue please contact to Healio ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |